The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 2 briefings matching “statin”

Reset all filters

Neurology

Neurology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

NEUROLOGY · PHASE I/II

Broccoli Compound Offers Hope for Friedreich Ataxia by Boosting Frataxin and Protecting Nerves

A naturally occurring compound in broccoli shows preclinical promise in treating Friedreich ataxia by boosting frataxin and protecting nerve cells, offering hope for an affordable, disease-modifying therapy. Friedreich ataxia currently lacks truly curative or broadly effective disease-modifying therapies.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · PHASE III

Broccoli Compound Shows Promise Against Friedreich Ataxia by Boosting Frataxin and Neuroprotection

A natural compound from broccoli significantly boosts frataxin levels and activates neuroprotective pathways in preclinical models of Friedreich ataxia, offering a promising, affordable disease-modifying therapy. Currently, there are no approved disease-modifying therapies for Friedreich ataxia, and patient management is predominantly symptomatic and supportive, encompassing physical therapy, cardiac interventions, and diabetes management.

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readScienceDailyNov 12, 2026

Interactive Fact Check